Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Nu.Q® Vet Cancer Test Product Deck

Thursday, April 3, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Volition has presented the Nu.Q® Vet Cancer Test, emphasizing its potential for early cancer detection in pets. The company has submitted a manuscript for the test in cats, which could result in a $5 million milestone payment upon publication. Additionally, the first automated version of the test has been developed in collaboration with Fujifilm Vet Systems.
Price reaction · baseline $10.5 (2025-04-03T13:33:00.000Z) · hit during market hours · 3 other VNRX headline(s) in the window, move may be shared
day 0 close
+6.2%
day 1
+1.4%
day 3 · peak
-12.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Early detection of cancer can significantly save lives.
  • The Nu.Q® Vet Cancer Test is being automated for better efficiency.
  • A manuscript submission may lead to a $5 million milestone payment.

Full Press Release Details

Presentation title: The Nu.Q ® Vet Cancer Test: Early Detection Can Save Lives

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is designed for early detection of cancer in pets.

What milestone payment is associated with the test?

A $5 million milestone payment is expected upon publication of a related manuscript.

Who collaborated with Volition on the test?

Fujifilm Vet Systems collaborated with Volition to automate the Nu.Q® Vet Cancer Test.

Why is early detection important?

Early detection of cancer can significantly improve treatment outcomes and save lives.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Nu.Q cancer detection Fujifilm Vet Systems veterinary test
Last updated: Apr 3, 2025

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk